SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bhagiradha Chemicals and Industries informs about outcome of board meeting

04 Nov 2022 Evaluate

In continuation to its letters dated October 25, 2022 and November 01, 2022, Bhagiradha Chemicals and Industries has informed that the Board of Directors of the Company at their meeting held today November 04, 2022 approved the following items: Un-Audited Financial Results (Standalone & Consolidated) as per Ind-AS for the Quarter/Half Year ended September 30, 2022, as reviewed and recommended by the Audit Committee, Limited Review Report of the Statutory Auditors of the Company on the Un-Audited Financial Results (Standalone & Consolidated) for the Quarter/Half Year ended September 30, 2022, Declared 1st Interim Dividend of Re 1.00 per equity share (10%) on the fully paid up equity shares of the face value of Rs 10 per share for the financial year 2022-23 and Post approval of the quarterly financial results in the same Board Meeting, the Board of Directors of the Company (‘Board’) discussed the status of setting up of the manufacturing plant of its subsidiary, Bheema Fine Chemicals (Wholly owned Subsidiary) in Kadechur, Karnataka. In this regard the Board has authorized the management to explore and evaluate availability of financial and other resources which will be required for setting up of the subsidiary’s new manufacturing plant. The meeting of the Board of Directors commenced at 12:30 pm (IST) and concluded at 3.00 pm (IST).

The above information is a part of company’s filings submitted to BSE.

Bhagiradha Chem Share Price

234.95 14.75 (6.70%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 656.15
PI Industries 3036.95
Bayer CropScience 4852.90
Sharda Cropchem 1101.50
Sumitomo Chemical 446.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×